Lezra

Product TA

Antineoplastic

Active Ingredient

Letrozole

Route Of Administration

Oral

Product type

Specialty


Product Details

Specialty

Oncology

Strength

2.5 mg

Product Form

Tablet

Registration Number

DKI1331701517A1

Consumer Information Leaflet


Additional products

Gemtavis

Product TA

Antineoplastic

Active Ingredient

Gemcitabine

Route Of Administration

IV

Product type

Specialty
View Product

Oncotaxel

Product TA

Antineoplastic

Active Ingredient

Docetaxel

Route Of Administration

IV

Product type

Specialty
View Product

Page Last Updated: 30 August 2021